Narrow search
Showing 1 - 10 of 491,754
Cover Image
Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation
Berndt, Ernst R.; Aitken, Murray L. - In: International journal of the economics of business 18 (2011) 2, pp. 177-201
Persistent link: https://www.econbiz.de/10009298466
Cover Image
Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation
Berndt, Ernst R. - 2014
- the latter frequently approaching 100%. Whereas in 1994, the generic price index fell from 100 to 80 in the 12 months … following initial generic entry and by 24 months to 65, in 2009 the comparable generic price indexes are 68 and 27, respectively … Medicare Part D, the average price per prescription declined by 21.3% from 2006 to 2009, rather than increasing by 25-28% as …
Persistent link: https://www.econbiz.de/10013069176
Cover Image
Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
Berndt, Ernst R. - 2010
- the latter frequently approaching 100%. Whereas in 1994, the generic price index fell from 100 to 80 in the 12 months … following initial generic entry and by 24 months to 65, in 2009 the comparable generic price indexes are 68 and 27, respectively … Medicare Part D, the average price per prescription declined by 21.3% from 2006 to 2009, rather than increasing by 25-28% as …
Persistent link: https://www.econbiz.de/10012462225
Cover Image
The prescribing physician’s influence on consumer choice between medically equivalent pharmaceuticals
Granlund, David; Rudholm, Niklas - In: Review of industrial organization : RIO 41 (2012) 3, pp. 207-222
Persistent link: https://www.econbiz.de/10009688210
Cover Image
Why brand drugs priced higher than generic equivalents
Iacocca, Kathleen; Sawhill, James; Zhao, Yao - In: International journal of pharmaceutical and healthcare … 9 (2015) 1, pp. 3-19
Persistent link: https://www.econbiz.de/10011302283
Cover Image
Generic competition in the US pharmaceutical industry
Saha, Atanu; Grabowski, Henry G.; Birnbaum, Howard; … - In: International journal of the economics of business 13 (2006) 1, pp. 15-38
Persistent link: https://www.econbiz.de/10003326770
Cover Image
Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market
Cavaliere, Alberto; Moayedizadeh, Ashin - 2022
Persistent link: https://www.econbiz.de/10014232582
Cover Image
Regulation of brands in the Indian pharmaceutical industry in the 1960s : examination of the Tariff Commission Report : 1968
Kanchan, Manu - In: IIMB Management Review 36 (2024) 1, pp. 83-92
. The Tariff Commission Report of 1968, a turning point in the price control policies of the 1960s, is examined. The …
Persistent link: https://www.econbiz.de/10014636929
Cover Image
Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement
Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252
Persistent link: https://www.econbiz.de/10011317852
Cover Image
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-Day exclusivity period
Olson, Luke M.; Wendling, Brett W. - 2013
Persistent link: https://www.econbiz.de/10010473653